Commit To Purchase Revance Therapeutics At $17.50, Earn 10.5% Annualized Using Options
October 02, 2018 at 11:49 AM EDT
Investors considering a purchase of Revance Therapeutics Inc (RVNC) shares, but cautious about paying the going market price of $24.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2019 put at the $17.50 strike, which has a bid at the time of this writing of $1.00..